Comments on Statistical Analysis of “Comparative Efficacy and Safety of Ilunocitinib and Oclacitinib for the Control of Pruritus and Associated Skin Lesions in Dogs With Atopic Dermatitis”
Veterinary Dermatology · 2026-12 · 37 (6) · 1052-1053
DOI: 10.1111/vde.70121 ↗Kurz gefasst
Leserbrief in der Zeitschrift Veterinary Dermatology, online erschienen am 26.08.2026. Verfasst von Michal Hakala und 3 weiteren Autor:innen. Beteiligte Einrichtung: MSD Czech Republic s.r.o., Prague, Czech Republic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- MSD Czech Republic s.r.o., Prague, Czech Republic.
- MSD Animal Health Innovation GmbH, Schwabenheim, Germany.
- Profinit EU s.r.o., Prague, Czech Republic.
ORCID-Profile: Michal Hakala, Inka Kuhlmann
Zitieren
APA
Hakala, M., Zschiesche, E., Hala, P., & Kuhlmann, I. (2026). Comments on Statistical Analysis of “Comparative Efficacy and Safety of Ilunocitinib and Oclacitinib for the Control of Pruritus and Associated Skin Lesions in Dogs With Atopic Dermatitis”. Veterinary Dermatology, 37(6), 1052-1053. https://doi.org/10.1111/vde.70121
Vancouver
Hakala M, Zschiesche E, Hala P, Kuhlmann I. Comments on Statistical Analysis of “Comparative Efficacy and Safety of Ilunocitinib and Oclacitinib for the Control of Pruritus and Associated Skin Lesions in Dogs With Atopic Dermatitis”. Veterinary Dermatology. 2026;37(6):1052-1053. doi:10.1111/vde.70121
BibTeX
@article{Hakala2026,
author = {Hakala, Michal and Zschiesche, Eva and Hala, Petr and Kuhlmann, Inka},
title = {Comments on Statistical Analysis of “Comparative Efficacy and Safety of Ilunocitinib and Oclacitinib for the Control of Pruritus and Associated Skin Lesions in Dogs With Atopic Dermatitis”},
journal = {Veterinary Dermatology},
year = {2026},
volume = {37},
number = {6},
pages = {1052--1053},
doi = {10.1111/vde.70121}
}
EUVIMED